Skip to content

The analgesic effect of different schemes of ropivacaine quadratus lumbostris block in the perioperative period of laparoscopic colorectal surgery under ultrasound guidance

The analgesic effect of different schemes of ropivacaine quadratus lumbostris block in the perioperative period of laparoscopic colorectal surgery under ultrasound guidance

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043949
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-03-08
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Carcinoma

Interventions

Low concentration ropivacaine (L) group:Two-sided QLBs were performed, with 0.25% ropivacaine (1/2 of the total local anesthetic amount calculated at 3mg/kg) on each side
Medium-concentration ropivacaine (M) group:Two-sided QLBs were performed with 0.375% ropivacaine (1/2 of the total local anesthetic amount calculated at 3mg/kg) on each side.
High-concentration ropivacaine (H) group :Two-sided QLBs were performed with 0.5% ropivacaine (1/2 of the total local anesthetic amount calculated at 3mg/kg) on each side.

Sponsors

Dongguan Houjie People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Adult patients who underwent elective laparoscopic colorectal surgery 1.ASA grade I-III; 2.Aged 18-75 years; 3.BMI of 18-24; 4.Operation time: 2-4h.

Exclusion criteria

Exclusion criteria: 1. Do not agree to participate in this study; 2. Incomplete medical history; 3. Can't understand or use VAS scoring system and PCIA pump; 4. Abnormal anatomical structure at the puncture site; 5. Have long history of analgesic drug use or allergy to ropivacaine and opioids; Patients with preoperative abnormal coagulation function or local infection, severe circulatory respiratory system and liver and kidney diseases.

Design outcomes

Primary

MeasureTime frame
Complete sensory block rate of surgical incision;

Secondary

MeasureTime frame
Postoperative VAS score;The consumption of Sufentanil after surgery;

Countries

China

Contacts

Public ContactWeifeng Liu

Department of Anesthesiology, Nanfang Hospital, Southern Medical University

sglwfeng01@21cn.com+86 13826003364

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026